Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
- Conditions
- Hypertension
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 801
- Registration Number
- NCT00274612
- Locations
- 🇦🇹
Rehabilitationszentrum für Herz- und Kreislauferkrankungen, Bad Tatzmannsdorf, Austria
🇦🇹Landeskrankenhaus Graz West, Graz, Austria
🇦🇹Univ.-Klinik für Innere Medizin III, Wien, Austria
Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1829
- Registration Number
- NCT00274547
- Locations
- 🇺🇸
Boehringer Ingelheim Investigational Site, Salt Lake City, Utah, United States
🇺🇸Hampton VA Medical Center, Hampton, Virginia, United States
🇺🇸Carl T. Hayden VA Medical Center, Phoenix, Arizona, United States
Headache Study to Compare Aggrenox Full Dose and Reduced Dose
- Conditions
- Cerebrovascular Accident
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-10-31
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 100
- Registration Number
- NCT00274586
- Locations
- 🇨🇳
Chang Gung Memorial Hospital, Taipei, Taiwan
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 653
- Registration Number
- NCT00274560
- Locations
- 🇺🇸
Temple University School of Medicine, Philadelphia, Pennsylvania, United States
🇬🇷University Hospital of Ioannina, Ioannina, Greece
🇺🇸University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 19
- Registration Number
- NCT00274027
- Locations
- 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 65
- Registration Number
- NCT00274066
- Locations
- 🇳🇱
Afdeling longziekten, Winschoten, Netherlands
🇳🇱Twenteborg Ziekenhuis, Almelo, Netherlands
🇳🇱Amphia Ziekenhuis, Breda, Netherlands
Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism
- Conditions
- HypertensionCoronary Arteriosclerosis
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 42
- Registration Number
- NCT00274144
- Locations
- 🇩🇪
Universitätsklinik des Saarlandes, Homburg/Saar, Germany
Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients
- Conditions
- Quality of LifeHIV Infections
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 158
- Registration Number
- NCT00274001
- Locations
- 🇮🇹
Ospedale degli Infermi di Biella, Biella, Italy
🇮🇹Ospedale Civile, Piacenza, Italy
🇮🇹Spedali Civili di Brescia, Brescia, Italy
Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 141
- Registration Number
- NCT00274040
- Locations
- 🇰🇷
Chung-ang University Hospital, Seoul, Korea, Republic of
🇰🇷Kangnam St. Mary's Hospital, Seoul, Korea, Republic of
🇰🇷Jeonnam National University Hospital, Kwangju, Korea, Republic of
Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1000
- Registration Number
- NCT00274014
- Locations
- 🇫🇷
Clinique Saint Sauveur, Angers, France
🇫🇷Hôpital Tenon, Paris cedex 20, France
🇫🇷Hôpital Charles Nicolle, Rouen cedex, France